Published in JAMA on December 21, 2011
The placebo phenomenon: implications for the ethics of shared decision-making. J Gen Intern Med (2012) 0.98
Tianma gouteng yin as adjunctive treatment for essential hypertension: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med (2013) 0.95
Are all placebo effects equal? Placebo pills, sham acupuncture, cue conditioning and their association. PLoS One (2013) 0.91
Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial. BMC Urol (2013) 0.90
Abstinence-related expectancies predict smoking withdrawal effects: implications for possible causal mechanisms. Psychopharmacology (Berl) (2013) 0.89
Distinct neural representations of placebo and nocebo effects. Neuroimage (2015) 0.82
Are open-Label Placebos Ethical? Informed Consent and Ethical Equivocations. Bioethics (2016) 0.80
Reevaluating the placebo effect in medical practice. Z Psychol (2014) 0.77
The placebo effect in asthma. Curr Allergy Asthma Rep (2014) 0.76
Causal diagrams, the placebo effect, and the expectation effect. Int J Gen Med (2013) 0.75
Changing the conversation about brain death. Am J Bioeth (2014) 8.71
Disclosing individual results of clinical research: implications of respect for participants. JAMA (2005) 8.15
A plea for pragmatism in clinical research ethics. Am J Bioeth (2008) 6.91
A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials. Hastings Cent Rep (2003) 6.00
Bench to bedside: mapping the moral terrain of clinical research. Hastings Cent Rep (2008) 4.98
Money and distorted ethical judgments about research: ethical assessment of the TeGenero TGN1412 trial. Am J Bioeth (2007) 4.81
Clinical trials and medical care: defining the therapeutic misconception. PLoS Med (2007) 3.77
What makes killing wrong? J Med Ethics (2012) 3.74
Communicating the results of clinical research to participants: attitudes, practices, and future directions. PLoS Med (2008) 3.05
Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One (2010) 3.03
Informed consent for pragmatic trials--the integrated consent model. N Engl J Med (2014) 3.01
Prescribing "placebo treatments": results of national survey of US internists and rheumatologists. BMJ (2008) 2.84
Rethinking risk-benefit assessment for phase I cancer trials. J Clin Oncol (2006) 2.73
Medicare's requirement for research participation as a condition of coverage: is it ethical? JAMA (2006) 2.43
Research with stored biological samples: what do research participants want? Arch Intern Med (2005) 2.43
Can research and care be ethically integrated? Hastings Cent Rep (2011) 2.15
Going off-label without venturing off-course: evidence and ethical off-label prescribing. Arch Intern Med (2009) 2.12
Deception in the pursuit of science. Arch Intern Med (2004) 1.99
Is placebo surgery unethical? N Engl J Med (2002) 1.94
Ethical issues in community-based participatory research: balancing rigorous research with community participation in community intervention studies. Prog Community Health Partnersh (2007) 1.90
Viewpoint: what is the best and most ethical model for the relationship between mainstream and alternative medicine: opposition, integration, or pluralism? Acad Med (2005) 1.79
Clinical pragmatism: a method of moral problem solving. Kennedy Inst Ethics J (1997) 1.74
Control group selection in critical care randomized controlled trials evaluating interventional strategies: An ethical assessment. Crit Care Med (2004) 1.71
The nocebo effect and its relevance for clinical practice. Psychosom Med (2011) 1.69
Is emergency research without initial consent justified?: the consent substitute model. Arch Intern Med (2010) 1.65
A normative justification for distinguishing the ethics of clinical research from the ethics of medical care. J Law Med Ethics (2005) 1.47
Misunderstanding, period. IRB (2011) 1.40
Clinical research and the physician-patient relationship. Ann Intern Med (2003) 1.39
Defining death: the importance of scientific candor and transparency. Intensive Care Med (2014) 1.38
Enrolling the uninsured in clinical trials: an ethical perspective. Crit Care Med (2003) 1.37
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry (2002) 1.29
Money, coercion, and undue inducement: attitudes about payments to research participants. IRB (2012) 1.29
Placebo Effects in Medicine. N Engl J Med (2015) 1.29
The clinician-investigator: unavoidable but manageable tension. Kennedy Inst Ethics J (2003) 1.28
The dead donor rule and organ transplantation. N Engl J Med (2008) 1.28
Pragmatic Randomized Trials Without Standard Informed Consent?: A National Survey. Ann Intern Med (2015) 1.20
The randomized controlled trial as a demonstration project: an ethical perspective. Am J Psychiatry (2009) 1.15
How placebo responses are formed: a learning perspective. Philos Trans R Soc Lond B Biol Sci (2011) 1.15
Placebo effect studies are susceptible to response bias and to other types of biases. J Clin Epidemiol (2011) 1.13
Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations. J Clin Oncol (2008) 1.12
Harnessing the placebo effect: the need for translational research. Philos Trans R Soc Lond B Biol Sci (2011) 1.11
Patients' attitudes about the use of placebo treatments: telephone survey. BMJ (2013) 1.10
Ethical framework for the use of sham procedures in clinical trials. Crit Care Med (2003) 1.08
Role of expectations in health. Curr Opin Psychiatry (2011) 1.08
Alternative medicine research in clinical practice: a US national survey. Arch Intern Med (2009) 1.07
The dead-donor rule and the future of organ donation. N Engl J Med (2013) 1.05
Justice and fairness in the Kennedy Krieger Institute lead paint study: the ethics of public health research on less expensive, less effective interventions. Am J Public Health (2006) 1.04
Screening and cognitive impairment: ethics of forgoing mammography in older women. J Am Geriatr Soc (2004) 1.00
Enrolling decisionally impaired adults in clinical research. Med Care (2002) 1.00
Misconceptions about coercion and undue influence: reflections on the views of IRB members. Bioethics (2012) 1.00
The placebo phenomenon: implications for the ethics of shared decision-making. J Gen Intern Med (2012) 0.98
Ethical aspects of research into the etiology of autism. Ment Retard Dev Disabil Res Rev (2003) 0.97
Clinical pragmatism: bridging theory and practice. Kennedy Inst Ethics J (1998) 0.96
Principles of early stopping of randomized trials for efficacy: a critique of equipoise and an alternative nonexploitation ethical framework. Kennedy Inst Ethics J (2005) 0.94
Clinical research before informed consent. Kennedy Inst Ethics J (2014) 0.94
Self-reported practices and attitudes of US oncologists regarding off-protocol therapy. J Clin Oncol (2008) 0.93
Evidence-based medicine: watching out for its friends. Perspect Biol Med (2005) 0.91
What counts as reliable evidence for public health policy: the case of circumcision for preventing HIV infection. BMC Med Res Methodol (2011) 0.90
Simulated patient studies: an ethical analysis. Milbank Q (2012) 0.89
Equipoise: asking the right questions for clinical trial design. Nat Rev Clin Oncol (2012) 0.89
Research ethics and misguided moral intuition. J Law Med Ethics (2004) 0.89
The research-clinical practice distinction, learning health systems, and relationships. Hastings Cent Rep (2013) 0.89
Twenty-five years of therapeutic misconception. Hastings Cent Rep (2008) 0.86
The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent. J Med Ethics (2012) 0.86
Vertebroplasty and the placebo response. Radiology (2011) 0.86
Ethical significance of ethics-related empirical research. J Natl Cancer Inst (2002) 0.85
Responding to medical pluralism in practice: a principled ethical approach. J Am Board Fam Med (2007) 0.85
Can we handle the truth? Legal fictions in the determination of death. Am J Law Med (2010) 0.84
What physician-investigators owe patients who participate in research. JAMA (2010) 0.84
When scientists deceive: applying the federal regulations. J Law Med Ethics (2009) 0.83
A prescription for ethical learning. Commentary. Hastings Cent Rep (2013) 0.83
The surgical intensivist as mediator of end-of-life issues in the care of critically ill patients. J Am Coll Surg (2003) 0.83
Waivers and Alterations to Consent in Pragmatic Clinical Trials: Respecting the Principle of Respect for Persons. IRB (2016) 0.83
Does the evidence make a difference in consumer behavior? Sales of supplements before and after publication of negative research results. J Gen Intern Med (2008) 0.82
A planned death in the family. Hastings Cent Rep (2009) 0.81
Ethical considerations in psychopharmacological research involving decisionally impaired subjects. Psychopharmacology (Berl) (2003) 0.80
Acupuncture for chronic low back pain. N Engl J Med (2010) 0.80
Placebo-controlled procedural trials for neurological conditions. Neurotherapeutics (2007) 0.80
Religion, clinicians, and the integration of complementary and alternative medicines. J Altern Complement Med (2009) 0.79
Can coverage be rescinded when negative trial results threaten a popular procedure? The ongoing saga of vertebroplasty. Health Aff (Millwood) (2011) 0.79
Viewpoint: Randomised controlled trials using invasive control interventions should be included in Cochrane Reviews. Cochrane Database Syst Rev (2011) 0.78
Factors that influence practitioners' interpretations of evidence from alternative medicine trials: a factorial vignette experiment embedded in a national survey. Med Care (2010) 0.78
The ethics of sham invasive intervention trials. Clin Trials (2009) 0.78
The ethics of research on enhancement interventions. Kennedy Inst Ethics J (2010) 0.78
The Stateville penitentiary malaria experiments: a case study in retrospective ethical assessment. Perspect Biol Med (2013) 0.78
Understanding and translating the knowledge about placebo effects: the contribution of psychology. Curr Opin Psychiatry (2014) 0.77
Placebo Effects and the Ethics of Therapeutic Communication: A Pragmatic Perspective. Kennedy Inst Ethics J (2016) 0.77
Counterpoint: are donors after circulatory death really dead, and does it matter? No and not really. Chest (2010) 0.77
The patient's work. Camb Q Healthc Ethics (2007) 0.77
Evidence, errors, and ethics. Perspect Biol Med (2014) 0.76
To publish or not to publish? J Lab Clin Med (2005) 0.75
Treatment of acute migraine. Lancet (2002) 0.75
End-of-life care for patients with dementia. N Engl J Med (2004) 0.75
Painful deception. Science (2004) 0.75
Academic-industrial relationships. N Engl J Med (2005) 0.75
Direct-to-consumer advertising and physician prescribing. JAMA (2005) 0.75
Placebo research and the spirit of informed consent. Psychosom Med (2005) 0.75
Justice and health care in the rheumatic diseases. HSS J (2005) 0.75
Controversies about brain death. JAMA (2009) 0.75